Prefilled automatic infusion device

By utilizing a high-volume automated infusion device with hyaluronidase preparations and a specific pressure range, the problem of delivering large volumes of drugs that existing devices struggle to deliver has been solved, achieving efficient and comfortable drug delivery and improving the convenience of treatment for patients.

CN122421998APending Publication Date: 2026-07-17HALOZYME INC
View PDF 32 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HALOZYME INC
Filing Date
2024-10-11
Publication Date
2026-07-17

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

在一个方面,本公开提供了一种用于递送包含透明质酸酶的药物的预填充自动输注装置。在另一个方面,本公开提供了一种在单次施用中施用高体积制剂以通过预填充自动输注装置治疗受试者的疾病或病症的方法。
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Combination therapy with an anti-hyaluronan agent and therapeutic agent

    US10137104B2

  • Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects

    US10265410B2

  • Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase

    US10301376B2

  • PH20 polypeptide variants, formulations and uses thereof

    US10865400B2

  • PH20 polypeptide variants, formulations and uses thereof

    US11041149B2